Table 2.
Patient information: Douglas Montreal Brain Bank
| Label | Age | Gender | Brain weight (g) | PMI (h) | Diagnosis | RIN |
|---|---|---|---|---|---|---|
| Ctr1 | 74 | F | 1365 | 11.00 | Normal | 7.4 |
| Ctr2 | 64 | M | 1530 | 20.75 | Normal | 6.3 |
| Ctr3 | 67 | M | 1300 | 24.75 | Normal | 6.6 |
| Ctr4 | 61 | M | 1500 | 6.25 | Normal | 6.8 |
| Ctr5 | 57 | F | 1250 | 35.75 | Normal | 6.2 |
| Ctr6 | 89 | M | 935 | 22.75 | Normal | 5.7 |
| Ctr7 | 72 | M | 1170 | 24.50 | Normal (brain infarct) | 5.4 |
| Ctr8 | 87 | M | 1190 | 29.00 | Normal (brain hypoperfusion) | 5.7 |
| FTLD1 | 74 | F | 890 | 19.00 | FTLD | 5.2 |
| FTLD2 | 62 | F | 625 | 31.50 | Pick’s disease | 6.5 |
| FTLD3 | 55 | M | 1000 | 18.75 | FTLD-U | 3.5 |
| FTLD4 | 86 | M | 1000 | 23.50 | FTLD-MAPT | 4.3 |
| FTLD5 | 67 | M | 750 | 30.00 | Pick’s disease | – |
| PSP1 | 88 | F | 1000 | 22.50 | Progressive supranuclear palsy + AD | 3.4 |
| PSP2 | 81 | F | 1045 | 40.50 | Progressive supranuclear palsy + AD | 4.7 |
| PSP3 | 65 | M | 1160 | 23.15 | Progressive supranuclear palsy | 4.5 |
| PSP4 | 60 | M | 1150 | 20.00 | Progressive supranuclear palsy | 3.7 |
| PSP5 | 61 | M | 1310 | 20.00 | Progressive supranuclear palsy | 3.8 |
| PSP6 | 72 | F | 1170 | 27.25 | Progressive supranuclear palsy | 4.6 |
| PSP7 | 69 | F | 1030 | 11.50 | Progressive supranuclear palsy | 7.4 |
| PSP8 | 63 | M | 1080 | 44.75 | Progressive supranuclear palsy | 5.6 |
| PSP9 | 92 | F | 865 | 13.50 | PSP + AD | 4.7 |
| AD1 | 79 | F | 900 | 10.75 | AD | 7.1 |
| AD2 | 85 | F | 1025 | 34.50 | AD | 5.8 |
| AD3 | 75 | F | 925 | 4.50 | AD | 4.9 |
| AD4 | 83 | M | 1137 | 28.00 | AD | 4.9 |
| AD5 | 71 | M | 1290 | 12.00 | AD + Hydrocephalus | 4.8 |
| AD6 | 79 | M | 1210 | 24.75 | AD senile | 4.9 |
| AD7 | 66 | M | 1075 | 8.50 | AD pre-senile | 7.1 |
| AD8 | 88 | M | 1240 | 24.75 | AD | 4.7 |